Insider trades
Vimal Mehta, CEO of BioXcel Therapeutics BTAIQ, has filed 0 purchases and 25 sales on the open market. Over the past 12 months that comes to a net sale of $21.2K. The latest trade was on 06/15.
Vimal Mehta
CEO and President
- Company
- BioXcel Therapeutics BTAIQ
- First filing
- 23/03/16
- Trades
- 93 trades
- Buys / sales
- 0 / 25
- 12-month net buying
- −$21.2K
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 05/20 | 05/22 | 19,419 sh | $1.09 | $21,166.71 | −21.8% |
BTAIQ | Open-market sale10b5-1 plan | 24/12/16 | 24/12/17 | 3,117 sh2 trades | $0.36avg. | $1,122.12 | −5.0% |
BTAIQ | Open-market sale10b5-1 plan | 24/09/16 | 24/09/17 | 1,982 sh2 trades | $0.69avg. | $1,367.58 | −3.7% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/06/17 | 24/06/18 | 2,134 sh | $1.28 | $2,731.52 | −4.3% |
BTAIQ | Open-market sale | 24/06/04–24/06/05 | 24/06/06 | 1,427,494 sh5 trades | No stated value | No stated value | −15.7% |
BTAIQ | Open-market sale10b5-1 plan | 24/04/04 | 24/04/08 | 5,268 sh2 trades | $2.62avg. | $13,802.16 | −10.8% |
BTAIQ | Open-market sale10b5-1 plan | 23/06/15–23/06/16 | 23/06/16 | 60,000 sh5 trades | $20.86avg. | $1,251,726.98 | −60.1% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 23/05/22 | 23/05/24 | 6,500 sh | $25.79 | $167,635 | −14.8% |
BTAIQ | Open-market sale | 23/03/20–23/03/21 | 23/03/22 | 64,500 sh6 trades | $18.97avg. | $1,223,313.42 | −80.2% |